INSM Earnings Insmed Incorporated
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–29 of 29
| Q2 2026 | 2026-06-30 | -0.82 | 2026-08-06 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.76 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -6.42 | 2026-02-19 | 10-K |
| Q3 2025 | 2025-09-30 | -4.89 | 2025-10-30 | 10-Q |
| Q2 2026 | 2025-06-30 | -3.12 | 2026-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.42 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -5.57 | 2026-02-19 | 10-K |
| Q3 2025 | 2024-09-30 | -4.27 | 2025-10-30 | 10-Q |
| Q2 2025 | 2024-06-30 | -3.02 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.06 | 2025-05-08 | 10-Q |
| FY 2025 | 2023-12-31 | -5.34 | 2026-02-19 | 10-K |
| Q3 2024 | 2023-09-30 | -4.06 | 2024-10-31 | 10-Q |
| Q2 2024 | 2023-06-30 | -2.95 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.17 | 2024-05-09 | 10-Q |
| FY 2024 | 2022-12-31 | -3.91 | 2025-02-20 | 10-K |
| Q3 2023 | 2022-09-30 | -2.68 | 2023-10-26 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.60 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.80 | 2023-05-04 | 10-Q |
| FY 2023 | 2021-12-31 | -3.88 | 2024-02-22 | 10-K |
| Q3 2022 | 2021-09-30 | -2.93 | 2022-10-27 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.97 | 2022-08-04 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.89 | 2022-05-05 | 10-Q |
| FY 2022 | 2020-12-31 | -3.01 | 2023-02-23 | 10-K |
| Q3 2021 | 2020-09-30 | -2.00 | 2021-10-28 | 10-Q |
| Q2 2021 | 2020-06-30 | -1.38 | 2021-08-05 | 10-Q |
| FY 2021 | 2019-12-31 | -3.01 | 2022-02-17 | 10-K |
| FY 2011 | 2011-12-31 | -2.95 | 2012-03-13 | 10-K |
| FY 2011 | 2010-12-31 | -0.49 | 2012-03-13 | 10-K |
| FY 2011 | 2009-12-31 | 9.30 | 2012-03-13 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.